DYNAVAX TECHNOLOGIES CORPDVAX
| Dec 31,
2011 | Dec 31,
2012 | Dec 31,
2013 | Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 |
|---|
| Product | - | - | - | - | - | - | - | 7 | 35 | 39 | 437 | 714 |
|---|
| Other Revenue | - | - | - | - | - | - | - | - | 0 | 7 | 2 | 9 |
|---|
| Total revenues | 22 | 10 | 11 | 11 | 4 | 11 | 0 | 8 | 35 | 47 | 439 | 723 |
|---|
| Cost of sales - product | - | - | - | - | - | - | - | - | 10 | 11 | - | - |
|---|
| Cost, Amortization | - | - | - | - | - | - | - | 11 | 9 | 3 | - | - |
|---|
| Research and development | 51 | 49 | 51 | 85 | 87 | 84 | 65 | 75 | 62 | 29 | 32 | 47 |
|---|
| Selling, general and administrative | - | - | - | - | - | - | 27 | 65 | 75 | 79 | 100 | 131 |
|---|
| Gain on sale of assets | - | - | - | - | - | - | - | - | - | 7 | 1 | 1 |
|---|
| Restructuring | - | - | - | - | - | - | 3 | - | 13 | - | - | - |
|---|
| Total operating expenses | 69 | 77 | 78 | 102 | - | - | - | - | 170 | 115 | 305 | 439 |
|---|
| Income (loss) from operations | -48 | -68 | -66 | -91 | -105 | -111 | -96 | -153 | -135 | -68 | 134 | 284 |
|---|
| Interest income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | 3 | 1 | 0 | 8 |
|---|
| Interest expense | 2 | 2 | - | 0 | 1 | - | - | 9 | 17 | 19 | 11 | 7 |
|---|
| Sublease income | - | - | - | - | - | - | - | - | 3 | 8 | 8 | 8 |
|---|
| Loss on debt extinguishment | - | - | - | - | -2 | - | - | - | - | - | -5 | - |
|---|
| Change in fair value of warrant liability (Note 14) | - | - | - | - | - | - | - | - | 8 | -4 | 49 | -2 |
|---|
| Other | 1 | -0 | -0 | 0 | 0 | -2 | -0 | -0 | 1 | -1 | 1 | 0 |
|---|
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total | - | - | - | - | - | - | - | - | - | - | 78 | 294 |
|---|
| Provision for income taxes | - | - | - | - | - | - | - | - | - | - | 1 | 1 |
|---|
| Net income (loss) | -49 | -70 | -67 | -91 | -107 | -112 | -95 | -159 | -153 | -75 | 77 | 293 |
|---|
| Undistributed earnings allocated to participating securities | - | - | - | - | - | - | - | - | - | - | 5 | 0 |
|---|
| Net income (loss) allocable to common stockholders, basic | - | - | -75 | -91 | -107 | - | - | - | -156 | -75 | 72 | 293 |
|---|
| Earnings Per Share, Basic | - | - | - | - | - | - | - | - | - | -0.75 | 0.62 | 2.32 |
|---|
| Earnings Per Share, Diluted | - | - | - | - | - | - | - | - | - | -0.78 | 0.57 | 1.97 |
|---|